SCHEMBL27745442

SCHEMBL27745442

CC(=O)Oc1c2ccccc2nn1C

nearest known ligand 0.44

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
▸ ATM Q13315 1/20 0.44
▸ MPO P05164 11/20 0.42
▸ NPC1 O15118 1/20 0.41
▸ ALDH1A1 P00352 1/20 0.41
▸ RAB9A P51151 1/20 0.41
▸ SMN1; SMN2 Q16637 1/20 0.41
▸ KDM5A P29375 1/20 0.39
▸ KDM4C Q9H3R0 1/20 0.39
▸ KDM5B Q9UGL1 1/20 0.39
▸ NPSR1 Q6W5P4 1/20 0.39
▸ SLC22A6 Q4U2R8 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27654482 0.80 MPO (0.65) MPONPC1ALDH1A1RAB9ASMN1; SMN2
SCHEMBL27763782 0.80 ATM (0.51) ATMMPONPC1ALDH1A1RAB9A
SCHEMBL27882430 0.79 ATM (0.51) ATMMPONPC1ALDH1A1RAB9A
SCHEMBL20132949 0.77 MPO (0.61) ATMMPOALDH1A1
SCHEMBL27615502 0.76 GRM2 (0.37) ALDH1A1SMN1; SMN2NPSR1SLC22A6
SCHEMBL28799922 0.74 ATM (0.46) ATMMPONPC1ALDH1A1RAB9A
SCHEMBL17324739 0.74 KDM5A (0.42) ATMNPC1ALDH1A1RAB9AKDM5A
SCHEMBL3712946 0.74 MPO (0.45) ATMMPO
SCHEMBL1563562 0.70 KDM5A (0.48) ALDH1A1SMN1; SMN2KDM5AKDM4CKDM5B
SCHEMBL1562180 0.70 ALDH1A1 (0.49) ALDH1A1SMN1; SMN2KDM5AKDM4CKDM5B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101558057-B 2 -alkyl- indazole compounds for the treatment of certain cns-related disorders ACRAF 2013-05-01 — — CN disclosed
CN-101558057-A 2 -alkyl- indazole compounds for the treatment of certain cns-related disorders ACRAF (IT) 2009-10-14 — — CN disclosed
CN-101466703-A Heterocyclic GABA-alpha subtype selective receptor modulators HOFFMANN LA ROCHE (CH) 2009-06-24 — — CN disclosed
Send feedback